Skip to main content
Clinical Trials/NCT07200960
NCT07200960CompletedNot Applicable

Analgesic Efficacy of Erector Spinae Plane Block Versus Retrolaminar Block in Patients Undergoing Major Oncological Breast Surgery: a Randomized Controllled Trial

Shaukat Khanum Memorial Cancer Hospital & Research Centre1 site in 1 country90 target enrollmentStarted: February 1, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
90
Locations
1
Primary Endpoint
Comparison of pain score of patients receiving ESPB and retrolaminar block

Study Overview

Brief Summary

The study aims to compare the efficacy in pain control and total opioid consumption after the use of ESPB and retrolaminar block in patients undergoing major oncological breast surgery..

Detailed Description

The study aims to compare the efficacy in pain control and total opioid consumption after the use of ESPB and retrolaminar block in patients undergoing major oncological breast surgery..

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Masking Description

will be asked regarding the group of blocks being employed.

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Female patients between 18- 60 years ASA 1 and 2

Exclusion Criteria

  • •Patient refusal Allergic reaction infection emergency case BMI >35

Arms & Interventions

Patient receiving ESPB for major oncological breast surgery

Experimental

Patient receiving ESPB for major oncological breast surgery

Intervention: ESPB (Procedure)

Patient receiving Retrolaminar block for major oncological breast surgery

Experimental

Patient receiving ESPB for major oncological breast surgery

Intervention: ESPB (Procedure)

Outcomes

Primary Outcomes

Comparison of pain score of patients receiving ESPB and retrolaminar block

Time Frame: 2hours post surgery

Numeric rating scale score

Secondary Outcomes

  • Comparison of total opioid consumption in 24 hours of patients receiving ESPB and retrolaminar block(24 hours post surgery)

Investigators

Sponsor
Shaukat Khanum Memorial Cancer Hospital & Research Centre
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials